Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).
- LSG results in greater weight loss than ESG up to two years post-operation.
- ESG significantly reduces the risk of adverse events, including de novo GERD.
Consider ESG for patients seeking safer bariatric options or those with GERD concerns.
Journal Article by LaPlante G, Cheema S (…) Switzer NJ et 6 al. in Surg Endosc
© 2026. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.